Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.8 - $4.98 $225,248 - $1.4 Million
-281,561 Reduced 91.82%
25,100 $20,000
Q4 2022

Feb 14, 2023

BUY
$1.88 - $36.45 $126,339 - $2.45 Million
67,202 Added 28.06%
306,661 $729,000
Q3 2022

Nov 14, 2022

BUY
$2.5 - $37.95 $598,647 - $9.09 Million
239,459 New
239,459 $544,000
Q2 2022

Aug 15, 2022

SELL
$1.75 - $11.34 $35,525 - $230,202
-20,300 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$10.21 - $20.29 $207,263 - $411,887
20,300 New
20,300 $207,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.54B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.